The Latest Breaking News on Pharma

A whale with a lot of money to spend has taken a noticeably bearish stance on Biogen. Looking at options history for Biogen (NASDAQ:BIIB) we detected 12 strange trades.

Miriam Stoppard discusses new research from Oxford which refutes the commonly held myth that statins are responsible for muscle pain

Years of sometimes confusing messaging on Covid has left half the people eligible for antiviral treatment unaware of it

A top World Health Organization official says Uganda’s Ebola outbreak is “rapidly evolving” a month after the disease was reported in the East African country

US and German-based HMNC Brain Health (HMNC Holding GmbH), a clinical stage biopharma company pioneering precision psychiatry, has raised nearly $14 million (EUR 14.3 million) in the closing of the first of two expected funding series, bringing the total capital raised to date to over $41 million (EUR 42.3 million.)…

The new mutant strain nicknamed the 'nightmare variant' is resistant to immunity has spread across several countries so far including a number in the US, Asia and Europe

Cache of documents seen by Guardian detail effort to refute scientific research into paraquat and derail nomination of key EPA adviser

Congress may still try to reform the FDA's accelerated approval process this year.

The French unit of German pharmaceuticals firm Merck has been charged with willful commercial deception for failing to inform patients of changes to a thyroid treatment that could result in serious side-effects.

An infectious disease expert has said XBB is one of a 'slew' of fast-spreading variants.

Some rather alarming headlines recently circulated about the newest members of the omicron family. “Nightmare COVID variant,” read one. “The most immune-evasive COVID variants yet.” Or, as one would-be pandemic influencer said in a tweet shared thousands of times: “MOTHER OF GOD… #COVID variants worse than CDC has been admitting.”